Analgesic effect and plasma ropivacaine concentrations after ultrasound-guided peripheral nerve block and postoperative continuous wound infusion in patients undergoing gynecological laparotomy
Not Applicable
- Conditions
- patients scheduled for gynecological laparotomy under general anesthesia
- Registration Number
- JPRN-UMIN000008697
- Lead Sponsor
- Sumitomo Hospital Department of Anesthesia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.over ASA-PS4 2.epidural anesthesia 3.laparoscopic surgery 4.allergy in ropivacaine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual analog scale (VAS) at rest and at mobilization, assessed at 3, 24,48 and 72hours after surgery
- Secondary Outcome Measures
Name Time Method 1.Plasma ropivacaine concentarations before and 16, 40 and 64hours after starting continuous wound infusion 2.Time to independent ambulations 3.Consumption of rescue analgesia at 24,48,72hours after surgery 4.Incidence of nausea and vomitting 5.Ocurrence of local anesthetic intoxication by ropivacaine 6.Ocurrence of adverse effects by cathters placed into the wound